MedTech Acquisition Corporation
MTAC · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | 86.1% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | – |
| G&A Expenses | $0 | $0 | $0 | – |
| SG&A Expenses | $0 | $0 | $0 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | $0 | $0 | $0 | – |
| Operating Expenses | $0 | $0 | $0 | – |
| Operating Income | -$0 | -$0 | -$0 | – |
| % Margin | -122.9% | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | – |
| Pre-Tax Income | -$0 | $0 | $0 | – |
| Tax Expense | -$0 | $0 | $0 | – |
| Net Income | -$0 | $0 | $0 | – |
| % Margin | -112.9% | – | – | – |
| EPS | -1.06 | 0.18 | 0.15 | – |
| % Growth | -688.9% | 20% | – | – |
| EPS Diluted | -1.06 | 0.18 | 0.15 | – |
| Weighted Avg Shares Out | 0 | 0 | 0 | – |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | -$0 | $0 | $0 | – |
| Depreciation & Amortization | $0 | -$0 | -$0 | – |
| EBITDA | -$0 | -$0 | -$0 | – |
| % Margin | -122.9% | – | – | – |